Citations

Showing 10 of 108094 citations.

The Role of the Otolaryngologist in Early Recognition of Patients With ALS: A Case Report
Zambrano, Maria Daniela Orellana , Candelo, Estephanía , Rutt, Amy L. , Orellana Zambrano, M Daniela, Gomez, Estephania Candelo , Rutt, Amy L.

Mayo Clinic

Ear, Nose & Throat Journal | November 11, 2022 | Volume: 104 | Issue: 1_suppl | Pages: No page available

10.1177/01455613221120731 | PMID 36358031 Get It

This case report aims to raise awareness of the possibility of amyotrophic lateral sclerosis (ALS) diagnosis in patients presenting to the Otolaryngology Department. We describe the case of a 66-year-old woman with hoarseness who was evaluated by several physicians and was referred to an ALS specialist only a year after symptom onset. Our case highlights the importance of considering motor neuron etiologies in patients with voice complaints. Early identification and referral to a specialist are critical for accurate diagnosis and prognosis and may be the key to slowing the disease's progression.
Endoscopic ultrasound-guided gastroenterostomy for the management of gastric outlet obstruction: A large comparative study with long-term follow-up
Jaruvongvanich, Veeravich , Mahmoud, Tala , Law, Ryan , Levy, Michael J. , Marya, Neil B. , Abboud, Donna Maria , Ghazi, Rabih , Matar, Reem, Rapaka, Babusai , Buttar, Navtej , Truty, Mark J. , Aerts, Maridi , Messaoudi, Nouredin , Kunda, Rastislav , Abboud, Donna M, Abboud, Donna M , Dayyeh, Barham K. Abu , Chandrasekhara, Vinay , Storm, Andrew C. , Levy, Michael J. , Vargas, Eric J. , Marya, Neil B.

Mayo Clinic

Endoscopy International Open | November 10, 2022 | Volume: 11 | Issue: 01 | Pages: E60-E66

10.1055/a-1976-2279 | PMID 36644538 Get It

Abstract Background and study aims Gastric outlet obstruction (GOO) is traditionally managed with surgical gastroenterostomy (surgical-GE) and enteral stenting (ES). Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is now a third option. Large studies assessing their relative risks and benefits with adequate follow-up are lacking. We conducted a comparative analysis of patients who underwent EUS-GE, ES, or surgical-GE for GOO. Patients and methods In this retrospective comparative cohort study, consecutive patients presenting with GOO who underwent EUS-GE, ES, or surgical-GE at two academic institutions were reviewed and independently cross-edited to ensure accurate reporting. The primary outcome was need for reintervention. Secondary outcomes were technical and clinical success, length of hospital stay (LOS), and adverse events (AEs). Results A total of 436 patients (232 EUS-GE, 131 ES, 73 surgical-GE) were included. The median duration of follow-up of the entire cohort was 185.5 days (interquartile range 55.25–454.25 days). The rate of reintervention in the EUS-GE group was lower than in the ES and surgical-GE groups (0.9 %, 12.2 %, and 13.7 %, P < 0.0001). Technical success was achieved in 98.3 %, 99.2 %, and 100 % (P = 0.58), and clinical success was achieved in 98.3 %, 91.6 %, and 90.4 % (P < 0.0001) in the EUS-GE, ES, and surgical-GE groups, respectively. The EUS-GE group had a shorter LOS (2 days vs. 3 days vs. 5 days, P < 0.0001) and a lower AE rate than the ES and surgical-GE groups (8.6 % vs. 38.9 % vs. 27.4 %, P < 0.0001). Conclusion This large cohort study demonstrates the safety and palliation durability of EUS-GE as an alternative strategy for GOO palliation in select patients.
Histopathological features of pemphigoid gestationis and polymorphic eruption of pregnancy: A blinded retrospective comparative study of 31 cases
Baban, Farah , Xie, Fangyi , Lehman, Julia S. , Theiler, Regan N. , Johnson, Emma F. , Theiler, Regan, Davis, Dawn M., Lehman, Julia S , Theiler, Regan , Todd, Austin W. , Davis, Dawn Marie R.

Mayo Clinic

Journal of Cutaneous Pathology | November 10, 2022 | Volume: 50 | Issue: 4 | Pages: 358-363

10.1111/cup.14358 | PMID 36357351 Get It

Abstract Background Pemphigoid gestationis (PG) and polymorphic eruption of pregnancy (PEP) are pregnancy‐related dermatoses. Definitive diagnosis often relies upon histopathology and direct immunofluorescence (DIF). PG is associated with fetal and neonatal risks, while PEP confers minimal risk. Objective We aimed to compare histopathologic features to determine key differentiators. Methods A retrospective cohort study of PG and PEP cases, with accompanying DIF, conducted from 1995 to 2020. Skin biopsies were examined independently in a blinded fashion by two dermatopathologists for a list of histopathological features. Results Twenty‐one cases of PG and 10 cases of PEP were identified. PG had significantly denser eosinophils than PEP (mean 155 vs. 48 cells/5 hpf; p < 0.018). PG was also noted to have eosinophilic spongiosis and eosinophils at the dermal–epidermal junction more frequently compared to PEP (80% PG vs. 10% PEP; p < 0.001). A mean cutoff value of 86 eosinophils and a mean optimal sensitivity and specificity of 81% and 83%, respectively, for eosinophils density's diagnostic power of PEP versus PG were achieved. Subepithelial separation was exclusively seen in PG (40% vs. 0%; p < 0.007). Conclusion Eosinophilic spongiosis, eosinophilic epitheliotropism, and dense superficial dermal eosinophils were diagnostic of PG. Given overlapping clinicopathologic features, however, DIF results with clinicopathologic correlation, remain the gold standard.
Hepatitis C–Seropositive Liver Transplants: A Multimethod Study to Evaluate Protocol Implementation
Faulkner, Sherilyn A., Aqel, Bashar , Leise, Michael D. , Dickson, Rolland C. , Martin, Matthew P. , Suri, Yash , Aqel, Bashar A. , Pungpapong, Surakit

Mayo Clinic

No container title available | November 10, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2023338/v1 Get It

Abstract Background: Starting in November 2017, 3 liver transplant centers in a single health care system tested and implemented a new protocol to begin accepting livers from hepatitis C virus–seropositive donors for seronegative liver transplant recipients. Although reports show an increase in donors after protocol implementation, there are no details regarding protocol uptake at each transplant center. Literature is limited on protocol implementation that is developed and disseminated by the same protocol producers. The purpose of this study was to evaluate the implementation of a new liver transplant protocol adopted at 3 transplant centers in the same health care system. Methods: A multimethod implementation study using interview, survey, and transplant data was conducted to develop a conceptual model of protocol implementation, identify facilitators of and barriers to implementation, and detect differences in implementation between 3 centers. Results: The conceptual model included 4 domains: rationale, development, implementation, and sustainability. Facilitators included clear, science-based rationale, input from multiple hepatologists, leadership support, and funded pilot data. Barriers included insurance coverage of posttransplant medication and donor field availability. A total of 94 physicians and staff at the 3 transplant centers completed the survey. Implementation factors were all rated moderately high to high at all 3 centers. One-way analysis of variance showed significant differences in mean implementation scores between the centers (F(2, 84)=11.65; P<.001) and between physicians at the 3 centers (F(2, 23)=4.65; P=.02); post hoc comparisons indicated that the scores for physicians differed only between the leading center and 1 participating center. Transplant numbers increased across all 3 centers from 2017 to 2021. Conclusions: Protocol implementation was successful across all 3 centers, especially at the leading transplant center where the protocol was developed. Future efforts should examine the appropriateness of the protocol for other organs (eg, heart, kidney) and additional medical outcome data (eg, mortality, morbidity, quality of life). Trial Registration: Not applicable
Sebaceous Carcinoma of the Eyelid: Proposed Nomenclature for Multifocal and Multicentric Disease
Magazin, Maja , Salomão, Diva R. , Castner, Nicholas B., Halbach, Caroline S., Tooley, Andrea A. , Halbach, Caroline, Dalvin, Lauren A.

Mayo Clinic

Ophthalmic Plastic & Reconstructive Surgery | November 10, 2022 | Volume: 39 | Issue: 2 | Pages: 117-122

10.1097/iop.0000000000002281 | PMID 36356187 Get It

Purpose: To review clinical presentations of periocular sebaceous carcinoma (SC) and introduce standardized nomenclature for multicentric and multifocal disease presentation. Methods: A comprehensive PubMed/Medline search was conducted to identify all articles reporting periocular multicentric or multifocal SC presentations. The authors also highlight an additional case of SC presenting with 2 clinically distinct tumor foci and complete secondary invasion of the lacrimal gland. Results: This review summarizes clinical presentations of periocular SC exhibiting discrete foci of microinvasion reported in the literature. Discrete microinvasion was associated with high rates of misdiagnosis (80%), simultaneous involvement of both upper and lower eyelids (80%), pagetoid spread (80%), multinodular growth (33%), local tumor spread (60%), previous eyelid manipulation (40%), and local recurrence (40%). Eyelid multifocality with clinically discrete nodules (42%) was associated with more advanced disease including orbital extension and regional invasion (80%). Conclusions: Despite previous reported associations with poorer outcomes, there is no consensus in the definition or nomenclature for discrete microinvasive or clinical disease presentations in periocular SC. The authors recommend defining multicentric disease as discrete foci of microinvasive tumor with basement membrane disruption and multifocal disease as discrete clinically evident nodules involving both the upper and lower eyelids. Differentiating between discrete microinvasive (multicentric) and clinically nodular (multifocal) disease may improve risk stratification to most accurately identify patients who require more aggressive management and surveillance.
Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Wieruszewski, Patrick M. , Macielak, Shea A. , Nei, Scott D. , Seelhammer, Troy G. , Nabzdyk, Christoph S. , Gerberi, Dana , Mara, Kristin C. , Hooten, W. Michael , Wittwer, Erica D. , Moman, Rajat N. , Nabzdyk, Christoph G. S., Nabzdyk, Christoph , Mara, Kristin C , Wieruszewski, Patrick M

Mayo Clinic

ASAIO Journal | November 10, 2022 | Volume: 69 | Issue: 2 | Pages: 137-144

10.1097/mat.0000000000001808 | PMID 36355803 Get It

Extracorporeal membrane oxygenation (ECMO) poses unique thrombotic and hemorrhagic risks, and the optimal anticoagulant choice is unknown. We systematically searched Ovid EBM Reviews, Ovid Embase, Ovid Medline, Scopus, and Web of Science Core Collection for randomized-, crossover-, retrospective cohort-, or parallel-designed clinical studies of adult patients receiving ECMO that compared heparin recipients with bivalirudin recipients. Meta-analysis was performed with random-effects models. The ROBINS-I tool was used to assess the risk of bias. Six retrospective observational studies met the inclusion criteria for the qualitative summary. Five studies were suitable for meta-analysis. Those who received heparin were more likely to experience circuit-related thrombosis (odds ratio [OR] 2.05, 95% confidence interval [CI] 1.25–3.37, p = 0.005, I 2 = 0%) and die (OR 1.62, 95% CI 1.19–2.21, p = 0.002, I 2 = 0%) compared with those who received bivalirudin. There were no differences in major bleeding events between heparin and bivalirudin recipients (OR 1.83, 95% CI 0.55–6.09, p = 0.33, I 2 = 82.7%). In retrospective settings compared with heparin anticoagulation, bivalirudin was associated with less circuit-related thrombotic events and greater survival in adults supported on ECMO, without contributing to more bleeding complications. Prospective controlled studies comparing heparin and bivalirudin in adult ECMO patients are warranted to corroborate these findings.
Neuropathological findings in COVID-19: an autopsy cohort
Eschbacher, Kathryn L. , Larsen, Rachel A. , Moyer, Ann M. , Majumdar, Ramanath, Reichard, R. Ross , Reichard, R Ross

Mayo Clinic

Journal of Neuropathology & Experimental Neurology | November 10, 2022 | Volume: 82 | Issue: 1 | Pages: 21-28

10.1093/jnen/nlac101 | PMID 36355625 Get It

Abstract The literature regarding the neuropathological findings in cases of SARS-CoV-2 infection, which causes coronavirus disease 2019 (COVID-19), is expanding. We identified 72 patients who died of COVID-19 (n = 48) or had recovered shortly before death (n = 24) and had autopsies performed at our institution (49 males, 23 females; median age at death 76.4 years, range: 0.0–95.0 years). Droplet digital polymerase chain reaction (ddPCR) for the detection of SARS-CoV-2 was performed (n = 58) in multiple brain regions. In cases the assay was successfully completed (n = 50), 98.0% were negative (n = 49) and 2% were indeterminate (n = 1). Most histologic findings were typical of the patient age demographic, such as neurodegenerative disease and arteriolosclerosis. A subset of cases demonstrated findings which may be associated with sequelae of critical illness. We identified 3 cases with destructive perivascular lesions with axonal injury, one of which also harbored perivascular demyelinating lesions. These rare cases may represent a parainfectious process versus sequelae of vascular injury. The lack of detectable SARS-CoV-2 by ddPCR or significant histologic evidence of direct infection suggests that active encephalitis is not a feature of COVID-19.
Developing a research agenda on climate change and health in primary care
Temte, Jonathan L. , Barrett, Bruce , Erickson, Rodney A. , Bell, Cristalyne , Erickson, Rodney

Mayo Clinic

Family Practice | November 10, 2022 | Volume: 40 | Issue: 3 | Pages: 519-521

10.1093/fampra/cmac130 | PMID 36461915 Get It

Dizziness as a missed symptom of central nervous system pathology: A review of malpractice cases
Ghaith, Summer , Voleti, Sandeep S. , Bellolio, Fernanda , Edlow, Jonathan A. , Lindor, Rachel A. , Bellolio, M Fernanda , Lindor, Rachel A

Mayo Clinic

Academic Emergency Medicine | November 10, 2022 | Volume: 30 | Issue: 5 | Pages: 589-591

10.1111/acem.14627 | PMID 36354754 Get It

Providing Fertility-Sparing Treatment Options for Fibroid Uterus
Alli, Adebisi , Thomas, Alyssa M., Kling, Juliana M. , Ball, Randall L., Kling, Juliana M

Mayo Clinic

Journal of Women's Health | November 10, 2022 | Volume: 31 | Issue: 11 | Pages: 1526-1528

10.1089/jwh.2022.0368 | PMID 36356182 Get It